The biopharma buffer market set for strong growth over next decade
Biopharma Buffer Market Market Overview: The biopharma buffer market is estimated to be valued at US$ 3.44 billion in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Buffers play a key role in stabilizing the pH level of solutions used for manufacturing biopharmaceutical products. They help maintain an optimal environment for cell growth and protein expression. Market Dynamics: One of the key drivers fueling growth in the biopharma buffer market is rising demand for monoclonal antibodies and recombinant proteins. Buffers are critical to the manufacturing processes of these complex biomolecules. They help control pH level during cell cultivation, purification, storage and transportation of finished biologics. Growing prevalence of chronic diseases is also propelling the development of novel biologics, thus driving buffer consumption. In addition, increasing outsourcing...